Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015 (2015), Article ID 283764, 8 pages
http://dx.doi.org/10.1155/2015/283764
Research Article

Immunohistochemical Expression of Dual-Specificity Protein Phosphatase 4 in Patients with Colorectal Adenocarcinoma

1Department of Pathology, College of Medicine, Hanyang University, Seoul 133-792, Republic of Korea
2Department of Surgery, College of Medicine, Hanyang University, Seoul 133-792, Republic of Korea

Received 27 October 2014; Revised 30 December 2014; Accepted 31 December 2014

Academic Editor: Vikram Kate

Copyright © 2015 Jongmin Sim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. C. Compton, “Colorectal carcinoma: diagnostic, prognostic, and molecular features,” Modern Pathology, vol. 16, no. 4, pp. 376–388, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, T. Murray, E. Ward et al., “Cancer statistics, 2005,” CA: A Cancer Journal for Clinicians, vol. 55, no. 1, pp. 10–30, 2005. View at Google Scholar
  3. W. Weng, F. Feng, H. Qin, and Y. Ma, “Molecular therapy of colorectal cancer: progress and future directions,” International Journal of Cancer, vol. 136, no. 3, pp. 493–502, 2015. View at Publisher · View at Google Scholar
  4. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, “Global cancer statistics, 2002,” CA: A Cancer Journal for Clinicians, vol. 55, no. 2, pp. 74–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Walker and P. Quirke, “Prognosis and response to therapy in colorectal cancer,” European Journal of Cancer, vol. 38, no. 7, pp. 880–886, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. J. Jun, S. M. Jang, H. L. Han, K. H. Lee, K.-S. Jang, and S. S. Paik, “Clinicopathologic signifcance of GULT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas,” World Journal of Gastroenterology, vol. 17, no. 14, pp. 1866–1873, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. L. T. Soumaoro, H. Uetake, T. Higuchi, Y. Takagi, M. Enomoto, and K. Sugihara, “Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer,” Clinical Cancer Research, vol. 10, no. 24, pp. 8465–8471, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. V. de Vriendt, W. de Roock, A. F. di Narzo et al., “DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotype,” Biomarkers, vol. 18, no. 6, pp. 516–524, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Saigusa, Y. Inoue, K. Tanaka et al., “Decreased expression of DUSP4 is associated with liver and lung metastases in colorectal cancer,” Medical Oncology, vol. 30, no. 3, article 620, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Waha, J. Felsberg, W. Hartmann et al., “Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells,” Cancer Research, vol. 70, no. 4, pp. 1689–1699, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. M. Keyse, “Dual-specificity MAP kinase phosphatases (MKPs) and cancer,” Cancer and Metastasis Reviews, vol. 27, no. 2, pp. 253–261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. W. H. Shen, J. Wang, J. Wu, V. B. Zhurkin, and Y. Yin, “Mitogen-activated protein kinase phosphatase 2: a novel transcription target of p53 in apoptosis,” Cancer Research, vol. 66, no. 12, pp. 6033–6039, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Cadalbert, C. M. Sloss, P. Cameron, and R. Plevin, “Conditional expression of MAP kinase phosphatase-2 protects against genotoxic stress-induced apoptosis by binding and selective dephosphorylation of nuclear activated c-jun N-terminal kinase,” Cellular Signalling, vol. 17, no. 10, pp. 1254–1264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Liu, F. Du, W. Chen, M. Yao, K. Lv, and P. Fu, “Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin,” Experimental Cell Research, vol. 319, no. 20, pp. 3140–3149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. H.-Y. Wang, Z. Cheng, and C. C. Malbon, “Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer,” Cancer Letters, vol. 191, no. 2, pp. 229–237, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Gröschl, M. Bettstetter, C. Giedl et al., “Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation,” International Journal of Cancer, vol. 132, no. 7, pp. 1537–1546, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. T. Yip-Schneider, A. Lin, and M. S. Marshall, “Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2,” Biochemical and Biophysical Research Communications, vol. 280, no. 4, pp. 992–997, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Chitale, Y. Gong, B. S. Taylor et al., “An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors,” Oncogene, vol. 28, no. 31, pp. 2773–2783, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Teutschbein, J. M. Haydn, B. Samans et al., “Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins,” BMC Cancer, vol. 10, article 386, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. M. Jang, J. M. Sim, H. Han et al., “Clinicopathological significance of CADM4 expression in invasive ductal carcinoma of the breast,” Journal of Clinical Pathology, vol. 66, no. 8, pp. 681–686, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. H.-T. Li, Y.-Y. Lu, Y.-X. An, X. Wang, and Q.-C. Zhao, “KRAS, BRAF and PIK3CA mutations in human colorectal cancer: relationship with metastatic colorectal cancer,” Oncology Reports, vol. 25, no. 6, pp. 1691–1697, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. C. P. Vaughn, S. D. Zobell, L. V. Furtado, C. L. Baker, and W. S. Samowitz, “Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer,” Genes Chromosomes and Cancer, vol. 50, no. 5, pp. 307–312, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. K. I. Patterson, T. Brummer, P. M. O'Brien, and R. J. Daly, “Dual-specificity phosphatases: critical regulators with diverse cellular targets,” The Biochemical Journal, vol. 418, no. 3, pp. 475–489, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. E. Armes, F. Hammet, M. de Silva et al., “Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers,” Oncogene, vol. 23, no. 33, pp. 5697–5702, 2004. View at Publisher · View at Google Scholar · View at Scopus